Rheumatology Advance Access originally published online on November 1, 2005
Rheumatology 2005 44(12):1579-1580; doi:10.1093/rheumatology/kei180
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© The Author 2005. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org
LETTER TO THE EDITOR |
Difficulties in the development of histological scoring of the inflamed temporal arteries in giant cell arteritis
Southend Hospital NHS Trust, Essex, UK and 1 Sahlgrenska University Hospital, Göteborg, Sweden
Correspondence to: B. Dasgupta, Department of Rheumatology, Southend Hospital NHS Trust, Prittlewell Chase, Westcliff on Sea, Essex SS0 0RY, UK. E-mail: bhaskar.dasgupta@southend.nhs.uk
| The first 10% of the full text of this article appears below. |
SIR, Giant cell arteritis (GCA) is a focal, granulomatous inflammation of medium and small-sized arteries in the elderly. Loss of vision occurs early and can be a presenting feature in 21.2% of patients [1]. The prognostic factors associated with neuro-ophthalmic complications are not entirely clear.
Temporal artery biopsy (TAB) is a clinically useful test with high predictive power [2]. A recent retrospective audit of 84 patients with TAB for suspected diagnosis of
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
D. Makkuni, A. Bharadwaj, K. Wolfe, S. Payne, A. Hutchings, and B. Dasgupta Is intimal hyperplasia a marker of neuro-ophthalmic complications of giant cell arteritis? Rheumatology, April 1, 2008; 47(4): 488 - 490. [Abstract] [Full Text] [PDF] |
||||
